Partners
We offer fair terms, capital, and support without interference.
We are the leading provider of funding solutions for life sciences innovation.
Market pioneer
Founded in 1996, Royalty Pharma has pioneered the royalty funding market and continued to innovate in life science funding.
Life sciences partner of choice
We are the global leader in biopharma royalty transactions, with a diverse portfolio of leading therapies.
Defying convention with new ideas
We create tailored funding solutions that advance our partners’ core mission.
Innovating new funding solutions, including synthetic royalties
Long-tenured expert team with deep scientific experience
Proud of partnerships that grow over multiple transactions
Team and process growing to address the large opportunity ahead
Able to integrate and interpret a broad and expanding information set
Unique platform for clinical trial analysis and market evaluation
The foundation of our culture rests on teamwork, critical thinking, innovation and the pursuit of excellence. We are nimble. We are laser-focused on making good investments in high quality, long duration therapies that generate attractive returns for our shareholders. By collaborating to accelerate innovation, we enable our partners to transform patient lives.
At Royalty Pharma we reward creative thinking – and new perspectives on old challenges
We hire talented people and invest in their growth to build engaged and diverse teams that are well-positioned to succeed.